Alport syndrome is a genetic disorder characterized by hereditary nephritis and deafness. It is caused by mutations in the COL4A5 gene, which is inherited in an X-linked pattern. Males experience more severe symptoms while females may only show blood in the urine. Symptoms include hematuria, nephropathy, hypertension, and progressive hearing loss beginning around age 10. Management involves maintaining renal function through treatments like hemodialysis or kidney transplantation as well as monitoring hearing and providing speech therapy and hearing aids. The prognosis is generally poor for affected males and fair to good for affected females.